Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Amy Vandenberg currently holds 11,764 shares of OBALON THERAPEUTICS INC (OBLN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Amy Vandenberg has been a net buyer of OBLN stock. They have purchased $10.0K and sold $0 worth of shares.
Amy Vandenberg's most recent insider trade was on Aug 6, 2019, when they purchased 2,500 shares at $4.00 per share.
Amy Vandenberg serves as Executive at OBALON THERAPEUTICS INC (OBLN). They have executed 7 insider transactions totaling $10.0K over their tenure at the company.
Amy Vandenberg holds the position of Executive at OBALON THERAPEUTICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Amy Vandenberg has shown a buying trading pattern, with $10.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Amy Vandenberg was on Aug 23, 2018, when they purchased $20.0K worth of OBLN shares. This transaction involved 10,989 shares at $1.82 per share.
Amy Vandenberg currently owns 11,764 shares of OBALON THERAPEUTICS INC (OBLN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Amy Vandenberg's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Amy Vandenberg has 7 Form 4 filings on record as an insider at OBALON THERAPEUTICS INC.
Set alerts for Amy Vandenberg and 40,000+ other insiders.